Institutional investors hold a majority ownership of CELG through the 81.06% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CARMIGNAC GESTION SA Bought 2.1 Million shares of Celgene
LAZARD ASSET MANAGEMENT LLC Bought 1.2 Million shares of Celgene
GOLDMAN SACHS ASSET MANAGEMENT L... Bought 1.2 Million shares of Celgene